A drug company has issued a nationwide recall of a type of drug used to treat attention deficit hyperactivity disorder (ADHD) due to potential potency concerns, according to notices released last week by the Food and Drug Administration (FDA).
Sun Pharmaceutical Industries initiated a recall of multiple lots of lisdexamfetamine dimesylate capsules on Oct. 28. The FDA on Oct. 30 determined that the recall is Class II. That means the product under recall could cause medically reversible or temporary adverse health consequences, although it is not likely to cause serious harm.
